REG - Integrated Diag Hdgs - Cancellation of Treasury Shares

Integrated Diagnostics HoldingsAnnouncement

08/10/2024 17:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241008:nRSH4282Ha&default-theme=true

RNS Number : 4282H  Integrated Diagnostics Holdings PLC  08 October 2024

 

Integrated Diagnostics Holdings plc

(the "Company")

 

Cancellation of Treasury Shares

 

08 October 2024

 

The Company today announces the cancellation of 18,673,728 treasury shares
initially transferred to treasury on the Completion of Treasury Shares Removal
Process referred to in the Company's announcement on 18 September 2024.

 

In accordance with Listing Rule 9.8.2 the Company discloses the following
information:

 

 Date of cancellation                                                            08 October 2024
 Number of ordinary shares held in treasury cancelled                            18,673,728
 Total number of ordinary shares held in treasury following the cancellation     0
 Total number of ordinary shares in issue following the cancellation (excluding  581,326,272
 shares held in treasury)

 

For further information please contact:

Integrated Diagnostics Holdings plc

Tarek Yehia

Investor Relations Director

T: +20 (0)2 3332 1126 | M: +20 10 6882 6678 |    tarek.yehia@idhcorp.com
(mailto:tarek.yehia@idhcorp.com)

 

Company Secretary

Company Matters

IDHLondon@linkgroup.co.uk (mailto:IDHLondon@linkgroup.co.uk)

 

-Ends-

 

About Integrated Diagnostics Holdings (IDH)

 IDH is a leading diagnostics services provider in the Middle East and Africa
offering a broad range of clinical pathology and radiology tests to patients
in Egypt, Jordan, Nigeria, Sudan and Saudi Arabia. The Group's core
brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as
Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both
in Sudan), and Biolab KSA (Saudi Arabia).  With over 40 years of
experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for
its portfolio of over 3 ,000 diagnostics tests. From its base
of 601 branches as of 31 December 2023, IDH served over 8. 5 million
patients and performed more than 36.1 million tests in 2023.  IDH will
continue to add laboratories through a Hub, Spoke and Spike business model
that provides a scalable platform for efficient expansion.  Beyond organic
growth, the Group targets expansion in appealing markets,
including acquisitions in the Middle Eastern, African, and East Asian
markets where its model is well-suited to capitalise on similar healthcare and
consumer trends and capture a significant share of fragmented markets.  IDH
is a Jersey-registered entity whose Shares are admitted to the equity shares
(transition) category (previously, the standard listing segment) of the
Official List of the UK Financial Conduct Authority and admitted to trading on
the main market for listed securities of the London Stock Exchange since May
2015 (ticker: IDHC).

 

Learn more at idhcorp.com (http://idhcorp.com/) .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSUWANRSWURRAA